KCT0008039进行中（未招募）未知
Clinical trial to evaluate the safety and efficacy for improvement of gastrocnemius hypertrophy of botulax® injection.
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 60(Year)（—）
- 性别
- All
入选标准
- •1) A person between the ages of 20 and 60 who want contour correction of the gastrocnemius muscle
- •2) A person who can follow the clinical trial procedure well and abide by the visit schedule
- •3) Those who voluntarily signed the consent form
排除标准
- •1) Patients with diseases that can affect neuromuscular function, such as myasthenia gravis, Eaton-Lamberton syndrome, amyotrophic lateral sclerosis, and motor neuropathy
- •2) Aminoglycoside antibiotics, curare-like agents, or drugs that inhibit neuromuscular function (muscle relaxants such as tubocurarine, dancrolen sodium, and baclofen, anticholinergics, and benzodiazepines) antibiotics, benzamide, tetracycline, lincomycin antibiotics, etc.)
- •3) Patients with a history of recent alcoholism or drug misuse
- •4) Patients with skin abnormalities such as infections, skin diseases, or scars at the injection site
- •5) If you have had other procedures that may affect gastrocnemius treatment within 6 months prior to baseline
- •6) Those who have received botulinum toxin preparations within 6 months before baseline
- •7) Patients with a history of facial nerve palsy or ptosis
- •8) Those taking aspirin, NSAIDs or anticoagulants
- •9) A woman who is pregnant, lactating, or of childbearing potential who does not agree to contraception by a medically accepted method for up to 8 weeks after drug administration
- •10) A person who has rapidly lost weight
- •11) Patients who are allergic or sensitive to investigational drugs or their ingredients
- •12) Those who are currently suffering from an acute disease
- •13) Those suffering from severe heart disease or respiratory disease
- •14) Patients who have participated in another clinical trial within 30 days before baseline or who have not passed the longer period of 5 times the half-life of the investigational drug of the clinical trial they participated in
- •15) Other patients who are not suitable for this test under the judgment of the investigator
研究者
相似试验
终止
不适用
Clinical trial to evaluate the safety and efficacy of synthetic bone graft substitutes with growth factors for posterior lumbar interbody fusioKCT0004738The Catholic University of Korea, Seoul St. Mary's Hospital20
已完成
1 期
Clinical trial of ShatPlus in SARS-CoV-2 Infection.CTRI/2020/05/025340BVG Life Sciences Ltd BVG Group60
已完成
不适用
Clinical trial to evaluate the safety and efficacy of cinnamon extracts on the improvement of bowel function and microfloraDiseases of the digestive systemKCT0003399Semyung University Oriental Medicine Hospital70
已完成
Unknown
Clinical trial to evaluate the safety and efficacy for improvement trapezius hypertrophy of botulax® injection.Factors influencing health status and contact with health servicesKCT0009443Asan Medical Center20
尚未招募
不适用
Clinical trial to evaluate the efficacy and safety of massage using a CMP-100 medical device in patients with shoulder-back myofascial pain syndromKCT0003971Wonkwang University, Gwangju Medical Center40